Evidence map›Paper›PMID 36826168›Full record

ArticleClinics and practice2023

Tumor-to-Tumor Metastases Involving Clear Cell Renal Cell Carcinomas: A Diagnostic Challenge for Pathologists Needing Clinical Correlation.

Claudia Manini, Claudia Provenza, Leire Andrés, Igone Imaz, Rosa Guarch, Raffaelle Nunziata, José I López

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinics and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Claudia ManiniDepartment of Pathology, San Giovanni Bosco Hospital, 10154 Turin, Italy.ORCID 0000-0002-5823-7137
Claudia ProvenzaDepartment of Pathology, San Giovanni Bosco Hospital, 10154 Turin, Italy.
Leire AndrésDepartment of Pathology, Cruces University Hospital, 48903 Barakaldo, Spain.
Igone ImazDepartment of Pathology, Cruces University Hospital, 48903 Barakaldo, Spain.
Rosa GuarchDepartment of Pathology, Hospital Virgen del Camino, 31008 Pamplona, Spain.
Raffaelle NunziataDepartment of Pathology, San Giovanni Bosco Hospital, 10154 Turin, Italy.
José I LópezBiomarkers in Cancer Unit, Biocruces-Bizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0000-0003-0842-5348
Ospedale San Giovanni Bosco · ITHospital de Cruces · ESBioCruces Health research Institute · ESHospital Virgen del Camino · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-to-tumor metastasis is a rare event which it is specifically up to pathologists to bring to light correctly. The histological identification of such tumor-to-tumor cases is simple when the respective histologies are different but can be problematic if the case includes two carcinomas with similar cytoarchitecture viewed one inside the other under the microscope. We report four cases of this condition in which clear cell renal cell carcinoma is involved, either as a receptor or as a donor, and remark on the difficulties in recognizing some of them. Appropriate clinical-pathological correlation, including a review of the patient's antecedents and radiological exams, would be a great help in routinely identifying tumor-to-tumor metastases.

Indexed as

clear cell renal cell carcinomaclinical-pathologic correlationhistopathologyimmunohistochemistrytumor samplingtumor-to-tumor metastasis

Identifiers

PMID36826168
PMCPMC9954947
OpenAlexW4321092851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.